2 completed, 1 withdrawn. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow TrueBinding, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TB006 in Participants With Alzheimer's Disease TB006, Placebo - Alzheimer's Disease | Phase 1 / Phase 2 | Completed | TrueBinding, Inc. | 154 | 2021-10-08 | 2023-11-18 |
| Sequential Dose-escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of TB006 in Healthy Subjects TB006, Sterile saline (Placebo) - Alzheimer Disease | Phase 1 | Completed | TrueBinding, Inc. | 48 | 2021-06-01 | 2024-12-09 |
| Study of TB006 in Outpatient Patients With Mild to Moderate COVID-19 TB006, Placebo - Covid19 | Phase 1 | Withdrawn | TrueBinding, Inc. | 2021-06-01 | 2022-05-18 |
Alzheimer Disease (2) · COVID-19 (1)
TB006 (3)
United States (2)
David Walling, MD (1) · George Haig, PharmD (1)